FDA approves updated Lupkynis (voclosporin) label to include long term data from the Aurora Clinical Program – Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Inc. announced that the FDA has approved a label update for Lupkynis. The updated label no longer includes language indicating that the safety and efficacy of… read more.
